Editorial: Current approaches to CRISPR/Cas9 delivery

Front Bioeng Biotechnol. 2022 Dec 9:10:1103007. doi: 10.3389/fbioe.2022.1103007. eCollection 2022.

Authors

Hasan Uludağ¹, Hamidreza Montazeri Aliabadi², Giedrius Gasiunas³

Affiliations

¹ University of Alberta, Edmonton, AB, Canada.
² School of Pharmacy, Chapman University, Irvine, CA, United States.
³ Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

No abstract available

Keywords: CRISPR; Cas9; gene editing; non-viral delivery; viral delivery.

Publication types

Editorial